Resistance Management for Cancer: Lessons from Farmers

Authors: Seyedi, Sareh, Harris, Valerie K., Kapsetaki, Stefania E., Saha, Daniel, Compton, Zachary, Yousefi, Rezvan, May, Alexander, Fakir, Efe, Boddy, Amy M., Gerlinger, Marco, Wu, Christina, Mina, Lida, Huijben, Silvie, Gouge, Dawn H., Cisneros, Luis, Ellsworth, Peter C., Maley, Carlo C.

Subject Terms: Quantitative Biology - Populations and Evolution

Access URL: http://arxiv.org/abs/2304.00402

Outcomes of the "BRCA Quality Improvement Dissemination Program": An initiative to improve patient receipt of cancer genetics services at five health systems

Authors: Bednar, Erica M., Chen, Minxing, Walsh, Michael T., Jr, Eppolito, Amanda L., Klein, Molly H., Teed, Kelly, Hodge, Brittany, Hunter, Jordan, Chao, Han Gill, Davis, Dillon, Serchion, Wilshauna, Yobbi, Cara, Krukenberg, Rebekah, Jenkinson, Sandra B., Moore, Jennifer J., Garcia, Cassandra, Gonzalez, Fatimaeliza, Murray, Towanna, Nielsen, Linda D., Ho, Brenda, Haas, Megan, Greenzweig, Sarah B., Anderson, Abby, Johnson, Christina, Morman, Nichole A., Bowdish, Elizabeth, Wise, Emaline, Cooper, Julia N., Russ, Pauline Kefalas, Tondo-Steele, Katelyn, de Gracia, Buonarotti F., Levin, Brooke, Mattie, Kristin, Zarnawski, Kathryn, Kalasinski, Molly, Stone, Jennifer, O'Brien, Caitlin, Bream, Alexa, Kennedy, Aidan M., Paul, Rachel A., Bilbao, Michelle, Romero, Maureen, Carr, Rebecca L., Siettmann, Jennifer M., Vercruyssen, Anna K., Leon, Kaycee, Arun, Banu K., Grainger, Andrew V., Warshal, David P., Bowman, Erin, Goedde, Timothy A., Halaharvi, Deepa, Rath, Kellie, Grana, Generosa, Mina, Lida, Lu, Karen H.

Source: In Gynecologic Oncology May 2023 172:106-114

Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience

Authors: Jahan, Nusrat ^{1, 2, a, ⁎}, Taraba, Jodi ², Boddicker, Nicholas J ³, Giridhar, Karthik V. ², Leon-Ferre, Roberto A. ², Tevaarwerk, Amye J. ², Cathcart-Rake, Elizabeth ², O'Sullivan, Ciara C. ², Peethambaram, Prema P. ², Hobday, Timothy J. ², Mina, Lida A. ⁴, Batalini, Felipe ⁴, Advani, Pooja ⁵, Sideras, Kostandinos ⁵, Haddad, Tufia C. ², Ruddy, Kathryn J. ², Goetz, Matthew P. ², Couch, Fergus J. ^{6, b}, Yadav, Siddhartha ^{2, b}

Source: In Clinical Breast Cancer April 2025 25(3):e211-e219

A Breast Radiology Department-operated, Proactive Same-day Program Identifies Pathogenic Breast Cancer Mutations in Unaffected Women

Authors: Loving, Vilert A., Luiten, Rebecca C., Siettmann, Jennifer M., Mina, Lida A.

Source: Academic radiology. 29(1):S239-S245

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100164973851.0x000001&indx=1&recIds=ETOCvdc_100164973851.0x000001

Prospective Study of Supplemental Screening With Contrast-Enhanced Mammography in Women With Elevated Risk of Breast Cancer: Results of the Prevalence Round.

Authors: Patel, Bhavika K., Carnahan, Molly B., Northfelt, Donald, Anderson, Karen, Mazza, Gina L., Pizzitola, Victor J., Giurescu, Marina E., Lorans, Roxanne, Eversman, William G., Sharpe Jr, Richard E., Harper, Laura K., Apsey, Heidi, Cronin, Patricia, Kling, Juliana, Ernst, Brenda, Palmieri, Jennifer, Fraker, Jessica, Mina, Lida, Batalini, Felipe, Pockaj, Barbara

Source: Journal of Clinical Oncology; 11/10/2024, Vol. 42 Issue 32, p3826-3836, 13p

QTc prolongation across CDK4/6 inhibitors: a systematic review and meta-analysis of randomized controlled trials.

Authors: Murad, Bruno, Reis, Pedro C A, Marinho, Alice Deberaldini, Comini, Ana Carolina Marin, Xavier, Débora Pinheiro, Pessoa, Beatriz Mella Soares, Raheem, Farah, Ernst, Brenda, Mina, Lida A, Batalini, Felipe

Source: JNCI Cancer Spectrum; Oct2024, Vol. 8 Issue 5, p1-10, 10p

Subject Terms: CYCLIN-dependent kinases, CYCLIN-dependent kinase inhibitors, RANDOMIZED controlled trials, BREAST cancer, CANCER patients

Precise and Programmable Detection of Mutations Using Ultraspecific Riboregulators

Authors: Hong, Fan, Ma, Duo, Wu, Kaiyue, Mina, Lida A., Luiten, Rebecca C., Liu, Yan, Yan, Hao, Green, Alexander A.

Source: In Cell 5 March 2020 180(5):1018-1032

Talazoparib in Patients with a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial

Authors: Hurvitz, Sara A., Gonçalves, Anthony, Rugo, Hope S., Lee, Kyung‐Hun, Fehrenbacher, Louis, Mina, Lida A., Diab, Sami, Blum, Joanne L., Chakrabarti, Jayeta, Elmeliegy, Mohamed, DeAnnuntis, Liza, Gauthier, Eric, Czibere, Akos, Tudor, Iulia Cristina, Quek, Ruben G.W., Litton, Jennifer K., Ettl, Johannes

Source: Oncologist. 25(3):e439-e450

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100103393024.0x000001&indx=1&recIds=ETOCvdc_100103393024.0x000001

Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status.

Authors: Telli, Melinda L., Litton, Jennifer K., Beck, J. Thaddeus, Jones, Jason M., Andersen, Jay, Mina, Lida A., Brig, Raymond, Danso, Michael, Yuan, Yuan, Symmans, William F., Hopkins, Julia F., Albacker, Lee A., Abbattista, Antonello, Noonan, Kay, Mata, Marielena, Laird, A. Douglas, Blum, Joanne L.

Source: Breast Cancer (13406868); Sep2024, Vol. 31 Issue 5, p886-897, 12p

Factors influencing U.S. women's interest and preferences for breast cancer risk communication: a cross-sectional study from a large tertiary care breast imaging center.

Authors: Austin, Jessica D., James, Emily, Perez, Rachel L, Mazza, Gina L., Kling, Juliana M., Fraker, Jessica, Mina, Lida, Banerjee, Imon, Sharpe, Richard, Patel, Bhavika K.

Source: BMC Women's Health; 6/21/2024, Vol. 24 Issue 1, p1-10, 10p

Subject Terms: AMERICAN women, BREAST imaging, DISEASE risk factors, BREAST cancer, RISK communication, YOUNG women, OLDER women

Geographic Terms: UNITED States

Patient-Reported Testing Burden of Screening Contrast-Enhanced Mammography.

Authors: Patel, Bhavika K., Gurudu, Rachana, Mazza, Gina, Sharpe, Richard E., Mina, Lida, Fraker, Jessica, Kling, Juliana M., Anderson, Karen, Hughes, Danny, Pockaj, Barbara

Source: Journal of the American College of Radiology; May2024, Vol. 21 Issue 5, p789-794, 6p

Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial

Authors: Mosher, Catherine E., Secinti, Ekin, Li, Ruohong, Hirsh, Adam T., Bricker, Jonathan, Miller, Kathy D., Schneider, Bryan, Storniolo, Anna Maria, Mina, Lida, Newton, Erin V., Champion, Victoria L., Johns, Shelley A.

Source: Supportive care in cancer. 26(6):1993-2004

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100125297693.0x000001&indx=1&recIds=ETOCvdc_100125297693.0x000001

Metastatic breast cancer patients' expectations and priorities for symptom improvement

Authors: Tometich, Danielle B., Mosher, Catherine E., Hirsh, Adam T., Rand, Kevin L., Johns, Shelley A., Matthias, Marianne S., Outcalt, Samantha D., Schneider, Bryan P., Mina, Lida, Storniolo, Anna Maria V., Newton, Erin V., Miller, Kathy D.

Source: Supportive care in cancer. 26(11):3781-3788

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100125298604.0x000001&indx=1&recIds=ETOCvdc_100125298604.0x000001

Testing Adaptive Therapy Protocols Using Gemcitabine and Capecitabine in a Preclinical Model of Endocrine-Resistant Breast Cancer.

Authors: Seyedi, Sareh, Teo, Ruthanne, Foster, Luke, Saha, Daniel, Mina, Lida, Northfelt, Donald, Anderson, Karen S., Shibata, Darryl, Gatenby, Robert, Cisneros, Luis H., Troan, Brigid, Anderson, Alexander R. A., Maley, Carlo C.

Source: Cancers; Jan2024, Vol. 16 Issue 2, p257, 25p

Subject Terms: THERAPEUTIC use of antimetabolites, BIOLOGICAL models, CONFIDENCE intervals, ANIMAL experimentation, ANTINEOPLASTIC agents, APOPTOSIS, GEMCITABINE, SURVIVAL rate, DESCRIPTIVE statistics, CELL proliferation, RESEARCH funding, BREAST tumors, DRUG resistance in cancer cells, HORMONE receptor positive breast cancer, MICE, OVERALL survival

Metastatic ER+ Breast Cancer: Mechanisms of Resistance and Future Therapeutic Approaches.

Authors: Raheem, Farah, Karikalan, Suganya Arunachalam, Batalini, Felipe, El Masry, Aya, Mina, Lida

Source: International Journal of Molecular Sciences; Nov2023, Vol. 24 Issue 22, p16198, 15p

Subject Terms: HORMONE receptors, THERAPEUTICS, ESTROGEN receptors, HORMONE therapy, BREAST cancer, GROWTH factors, BREAST

Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study.

Authors: Turner, Nicholas C., Laird, A. Douglas, Telli, Melinda L., Rugo, Hope S., Mailliez, Audrey, Ettl, Johannes, Grischke, Eva-Maria, Mina, Lida A., Balmaña, Judith, Fasching, Peter A., Hurvitz, Sara A., Hopkins, Julia F., Albacker, Lee A., Chelliserry, Jijumon, Chen, Ying, Conte, Umberto, Wardley, Andrew M., Robson, Mark E.

Source: NPJ Breast Cancer; 10/6/2023, Vol. 9 Issue 1, p1-9, 9p

Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study.

Authors: Litton, Jennifer K, Beck, J Thaddeus, Jones, Jason M, Andersen, Jay, Blum, Joanne L, Mina, Lida A, Brig, Raymond, Danso, Michael, Yuan, Yuan, Abbattista, Antonello, Noonan, Kay, Niyazov, Alexander, Chakrabarti, Jayeta, Czibere, Akos, Symmans, William F, Telli, Melinda L

Source: Oncologist; Oct2023, Vol. 28 Issue 10, p845-855, 11p, 1 Diagram, 4 Charts, 2 Graphs

Subject Terms: DRUG efficacy, RESEARCH, GENETIC mutation, CONFIDENCE intervals, CLINICAL trials, BRCA genes, HETEROCYCLIC compounds, RESEARCH methodology, TUMOR classification, RESEARCH funding, DESCRIPTIVE statistics, KAPLAN-Meier estimator, DATA analysis software, BREAST tumors, PATIENT safety

Targeted Therapies in Early-Stage Breast Cancer: Achievements and Promises

Authors: Sledge, George W., Jr, Jotwani, Aparna C., Mina, Lida

Source: In Surgical Oncology Clinics of North America 2010 19(3):669-679

Neoadjuvant talazoparib (TALA) in patients (pts) with germline BRCA1/2 (gBRCA1/2) mutation-positive, early HER2-negative breast cancer (BC): Exploration of tumor BRCA mutational status and zygosity and overall mutational landscape in a phase 2 study.

Authors: Telli, Melinda L., Litton, Jennifer Keating, Beck, Joseph Thaddeus, Jones, Jason M., Andersen, Jay, Mina, Lida A., Brig, Raymond, Danso, Michael A., Yuan, Yuan, Symmans, William Fraser, Abbattista, Antonello, Noonan, Kay, Mata, Marielena, Laird, Douglas, Blum, Joanne Lorraine

Source: Journal of clinical oncology. 39(15 suppl):554-554

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100174763990.0x000001&indx=1&recIds=ETOCvdc_100174763990.0x000001

First-in-human phase 1/1b expansion of PMD-026, an oral RSK inhibitor, in patients with metastatic triple-negative breast cancer.

Authors: Beeram, Muralidhar, Chalasani, Pavani, Wang, Judy S., Mina, Lida A., Shatsky, Rebecca Arielle, Trivedi, Meghna S., Wesolowski, Robert, Hurvitz, Sara A., Han, Hyo S., Patnaik, Amita, Pambid, Mary Rose, Jayanthan, Aarthi, Huynh, My-my, Los, Gerrit, Dunn, Sandra Elaine, Dorr, Andrew

Source: Journal of clinical oncology. 39(15 suppl):e13043-e13043

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173180226.0x000001&indx=1&recIds=ETOCvdc_100173180226.0x000001